This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Cleared by the FDA for both primary and revision indications, the system enters a limited market release throughout 2025, with full commercial launch anticipated in 2026. restor3d is a world leader in 3D printed patient specific musculoskeletal implants and driven by the belief that every patient deserves personalized care.
NEW YORK, February 25, 2025 – ( BUSINESS WIRE ) – Hospital for Special Surgery (HSS), the worlds leading academic medical center focused on musculoskeletal health, has appointed internationally acclaimed sports medicine surgeon Riley J. About HSS HSS is the worlds leading academic medical center focused on musculoskeletal health.
The investments will fuel the companys continued growth and the launch of four groundbreaking 3D printed product lines in 2025 and 2026. By leveraging advanced 3D printing and AI-driven design, we are restoring mobility and improving liveswhether its helping patients return to work, get back on the golf course, or simply walk without pain.
if net sales are between $346 million and $361 million) during Zimmer Biomet’s fiscal year 2026. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content